Literature DB >> 26371419

A novel mutation in DNAJB6, p.(Phe91Leu), in childhood-onset LGMD1D with a severe phenotype.

Tai-Seung Nam1, Wenting Li2, Suk-Hee Heo3, Kyung-Hwa Lee4, Anna Cho5, Jin-Hong Shin6, Young Ok Kim7, Jong-Hee Chae8, Dae-Seong Kim6, Myeong-Kyu Kim9, Seok-Yong Choi10.   

Abstract

To identify and characterize genetic mutation in a Korean family with limb-girdle muscular dystrophy 1 (LGMD1), we analyzed in the affected family members clinical features, DNAJB6 by Sanger sequencing, muscle structures by magnetic resonance imaging (MRI), and functional consequences of the identified mutation using a zebrafish model. The clinical phenotypes along with identification of a novel c.271T > C (p.(Phe91Leu)) mutation in DNAJB6 led to the diagnosis of LGMD1D in the affected family members. This mutation presents unique clinical and radiological features compared with other DNAJB6 mutants. All affected members examined showed reduced pulmonary function, and had nasal voice and dysphagia except the two members who were thirteen and twelve years of age at the time of examination. Muscle phenotypes developed between 8 and 11 years of age and were more severe as compared to previously reported LGMD1D patients with mutant DNAJB6. Patients' MRI scans exhibited early involvement of the lateral head of gastrocnemius, in contrast to its late involvement in reported LGMD1D cases. Functional study using zebrafish embryos demonstrated that p.Phe91Leu elicits more severe muscle defects than the reported p.Phe93Leu and p.Pro96Arg mutations. We conclude that a novel p.(Phe91Leu) mutation in DNAJB6 is associated with severe childhood-onset LGMD1D.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNAJB6; Human genetics; Limb-girdle muscular dystrophy; Magnetic resonance imaging; Zebrafish

Mesh:

Substances:

Year:  2015        PMID: 26371419     DOI: 10.1016/j.nmd.2015.08.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

Review 1.  Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Sabita Kawan; Bjarne Udd
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

2.  Two Korean Families with Limb-Girdle Muscular Dystrophy Type 1D Associated with DNAJB6 Mutations.

Authors:  Kitae Kim; Hyung Jun Park; Jung Hwan Lee; Jiman Hong; Suk Won Ahn; Young Chul Choi
Journal:  Yonsei Med J       Date:  2018-07       Impact factor: 2.759

Review 3.  DNAJB6 Myopathies: Focused Review on an Emerging and Expanding Group of Myopathies.

Authors:  Alessandra Ruggieri; Simona Saredi; Simona Zanotti; Maria Barbara Pasanisi; Lorenzo Maggi; Marina Mora
Journal:  Front Mol Biosci       Date:  2016-09-30

4.  A novel recessive mutation affecting DNAJB6a causes myofibrillar myopathy.

Authors:  Fang-Yuan Qian; Yu-Dong Guo; Juan Zu; Jin-Hua Zhang; Yi-Ming Zheng; Idriss Ali Abdoulaye; Zhao-Hui Pan; Chun-Ming Xie; Han-Chao Gao; Zhi-Jun Zhang
Journal:  Acta Neuropathol Commun       Date:  2021-02-08       Impact factor: 7.801

5.  Case Report: A Novel Splice-Site Mutation in DNAJB6 Associated With Juvenile-Onset Proximal-Distal Myopathy in a Chinese Patient.

Authors:  Guang Ji; Ning Wang; Xu Han; Yaye Wang; Jinru Zhang; Yue Wu; Hongran Wu; Shaojuan Ma; Xueqin Song
Journal:  Front Genet       Date:  2022-06-23       Impact factor: 4.772

Review 6.  DNAJ Proteins in neurodegeneration: essential and protective factors.

Authors:  Christina Zarouchlioti; David A Parfitt; Wenwen Li; Lauren M Gittings; Michael E Cheetham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

7.  Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations.

Authors:  Josef Finsterer
Journal:  Yonsei Med J       Date:  2018-10       Impact factor: 2.759

8.  The Author Reply: Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations.

Authors:  Kitae Kim; Young Chul Choi
Journal:  Yonsei Med J       Date:  2018-10       Impact factor: 2.759

9.  LGMD1D myopathy with cytoplasmic and nuclear inclusions in a Saudi family due to DNAJB6 mutation.

Authors:  Saeed A Bohlega; Sarah Alfawaz; Hussam Abou-Al-Shaar; Hindi N Al-Hindi; Hatem N Murad; Mohamed S Bohlega; Brian F Meyer; Dorota Monies
Journal:  Acta Myol       Date:  2018-09-01

10.  High-Efficiency Expression and Purification of DNAJB6b Based on the pH-Modulation of Solubility and Denaturant-Modulation of Size.

Authors:  Sara Linse
Journal:  Molecules       Date:  2022-01-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.